J F Laboratories Ltd


BSE: 523804 | NSE: JFLABS | ISIN: INE226C01019 
Market Cap: [Rs.Cr.] 3 | Face Value: [Rs.] 10
Industry: Chemicals

 Discuss this stock

Management Discussions

J. F. LABORATORIES LIMITED ANNUAL REPORT 2010-2011 MANAGEMENT DISCUSSION AND ANALYSIS I. INDUSTRY OUTLOOK: The economic scenario in India has been very buoyant though there is substantial amount of definitive business and infrastructural risks in setting up a green field project in India and more so in a high technology field. For reasons already noted, the Company's pioneering initiative could not be capitalized to its advantage due to its entry at very nascent stage of the industry. The growth of this sector for research, product development and processing tie-ups and ventures for the time being is more on reorganization of existing: enterprises or facilities with established players in the field. II. FINANCIAL PERFORMANCE-TERM LOANS/DEBENTURES: The Financial Institutions and Banks have already recovered their dues and charges against financial security of the Project assets and properties inasmuch as the same have already been auctioned and sold off during the earlier year by the Hon'ble Debts Recovery Tribunal, Mumbai. III. OUTLOOK ON OPPORTUNITIES, THREATS, RISKS AND CONCERNS: Given the above circumstances on the present status of the Company's affairs and the financial position of the Company, there is no outlook on opportunities, threats, risks and concern. IV. INTERNAL CONTROL SYSTEMS AND ADEQUACY: Given the present size and nature of its operations, the Company has effected various austerity measures and cost controls for its constricted activities and there exists reasonable and adequate internal control system within the Company.
J.F. LABORATORIES LIMITED ANNUAL REPORT 2009-2010 MANAGEMENT DISCUSSION AND ANALYSIS I. INDUSTRY OUTLOOK: The Indian bio-process industry has matured with global acceptance of our knowledge, entrepreneurial, skilled human resource base in the field. For reasons already noted, the Company's pioneering initiative could not be capitalized to its advantage due to its entry at very nascent stage of the industry. The growth of this sector for research, product development and processing tie-ups and ventures, is now visible with various players in the field. II. FINANCIAL PERFORMANCE - TERM LOANS / DEBENTURES: The Financial Institutions and Banks have already recovered their dues and charges against financial security of the Project assets and the same having been auctioned by the Hon'ble Mumbai Debts Recovery Tribunal as mentioned in Para 1 above. III. OUTLOOK ON OPPORTUNITIES, THREATS, RISKS AND CONCERNS: Given the present status of the Company's affairs and the financial position of the Company, there is no outlook on opportunities, threats, risks and concern as there is no project of the company. IV. INTERNAL CONTROL SYSTEMS AND ADEQUACY: In the above circumstances, the Company has effected various austerity measures and cost controls and given the present size and nature of its operations, the internal control systems are adequate.

Related News

 
No Related News

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Castrol India 16,708.71 37.25 25.73 20.39 71.4 104.3 0.00
Pidilite Inds. 14,063.18 30.83 8.12 17.46 26.6 30.3 0.22
Godrej Inds. 9,995.66 261.58 6.18 28.98 10.0 10.5 0.46
Guj Fluorochem 3,184.35 7.99 1.28 7.96 32.8 38.4 0.37
BASF India 2,488.31 20.65 2.18 11.06 10.0 12.9 0.16
Linde India 2,459.90 114.01 1.85 15.35 4.1 4.0 0.75
Solar Inds. 1,692.26 20.01 4.28 15.37 24.5 22.9 0.75
Clariant Chemica 1,134.12 12.02 2.26 10.23 20.5 27.7 0.00
Aarti Inds. 725.63 5.53 1.07 4.42 18.2 16.0 1.20
Tide Water Oil 640.85 10.18 0.75 6.36 20.9 28.7 0.00
Gulf Oil Corpn. 620.68 12.45 1.44 7.70 10.5 9.1 0.57
Wimco 482.78 0.00 74.28 0.00 0.0 0.0 0.10
Vivimed Labs. 448.88 12.22 1.62 10.64 18.8 13.6 1.19
Citurgia Biochem 417.96 0.00 -156.63 0.00 0.0 0.0 3.52
Inox Air Product 390.75 2.66 0.52 0.00 21.7 22.8 0.51

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

M Flork , Director 

S S Ranade , Director 

Alka N Poddar , Director 

S C Rane , Director & Company Secretary 


Company Head Office / Quarters:
D-3 MIDC Kurkumbh,
Daund Taluka,
Pune,
Maharashtra-413801
Phone :
Fax :
E-mail :
Web : http://
Registrars:
Sharex (India) Pvt. Ltd
Unit I Luthra Indus.
Andheri Kurla Road
SafedPool Andheri(E)
Mumbai - 400072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list ANZ Job Advertisements (MoM)
list EIA Natural Gas Storage Change
Results
list Havells India | Union Bank (I) | Dena Bank | Central Bank